November's reviewers of the month

IF 4.4 2区 医学 Q1 UROLOGY & NEPHROLOGY BJU International Pub Date : 2024-10-24 DOI:10.1111/bju.16541
{"title":"November's reviewers of the month","authors":"","doi":"10.1111/bju.16541","DOIUrl":null,"url":null,"abstract":"<p>Like most journals, BJUI relies on the hard work and dedication of its peer reviewers and we are grateful to them all. Each month the Editorial Team nominates peer reviewers whose reviews have stood out for their quality and timeliness and those selected as the best are highlighted on this page in recognition of their exceptional work.</p><p>Dr.Amar U. Kishan, Professor, is the Executive Vice Chair for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center.</p><p>Ben Tran is a Medical Oncologist based at Peter MacCallum Cancer Centre where he leads the Genitourinary (GU) Medical Oncology group. He is also a Clinician Scientist at the Walter and Eliza Hall Institute and is an Associate Professor within the Sir Peter MacCallum Department of Oncology at The University of Melbourne. Ben is Chair of the ANZUP Germ Cell Tumour Subcommittee, and also Chairs the Phase 1 Group within Cancer Trials Australia.</p><p>Ben is internationally recognised for his leadership in Early Drug Development and Real World Evidence in GU cancers. He has pioneered the development of novel immunotherapeutic approaches in prostate cancer, including T-cell redirected therapies and CAR-T cell therapy. Ben also continues to develop novel therapeutics for NMIBC and works towards improving survivorship in testicular cancer. Ben's clinical trial expertise is supplemented by his development of multi-national clinical registries in GU cancers.</p>","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"134 5","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bju.16541","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJU International","FirstCategoryId":"3","ListUrlMain":"https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.16541","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Like most journals, BJUI relies on the hard work and dedication of its peer reviewers and we are grateful to them all. Each month the Editorial Team nominates peer reviewers whose reviews have stood out for their quality and timeliness and those selected as the best are highlighted on this page in recognition of their exceptional work.

Dr.Amar U. Kishan, Professor, is the Executive Vice Chair for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center.

Ben Tran is a Medical Oncologist based at Peter MacCallum Cancer Centre where he leads the Genitourinary (GU) Medical Oncology group. He is also a Clinician Scientist at the Walter and Eliza Hall Institute and is an Associate Professor within the Sir Peter MacCallum Department of Oncology at The University of Melbourne. Ben is Chair of the ANZUP Germ Cell Tumour Subcommittee, and also Chairs the Phase 1 Group within Cancer Trials Australia.

Ben is internationally recognised for his leadership in Early Drug Development and Real World Evidence in GU cancers. He has pioneered the development of novel immunotherapeutic approaches in prostate cancer, including T-cell redirected therapies and CAR-T cell therapy. Ben also continues to develop novel therapeutics for NMIBC and works towards improving survivorship in testicular cancer. Ben's clinical trial expertise is supplemented by his development of multi-national clinical registries in GU cancers.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
11 月份的月度评论员
点击文章标题阅读更多内容。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BJU International
BJU International 医学-泌尿学与肾脏学
CiteScore
9.10
自引率
4.40%
发文量
262
审稿时长
1 months
期刊介绍: BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.
期刊最新文献
Beyond sensitivity: artificial intelligence and micro-ultrasonography in prostate cancer detection. Cytoreductive nephrectomy in the era of immune-checkpoint inhibitors: back to the future? Deep early tumour shrinkage in metastatic upper tract urothelial carcinoma treated with enfortumab vedotin plus pembrolizumab. Characteristics and outcomes of men presenting with complications of metastatic prostate cancer. Response to Lin et al.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1